English
简体中文
Total: £ 56.28
Published Date: 2026-04-13 | Pages: 123 | Tables: 119 | Pharma & Healthcare
The global Carbohydrate Antigen 19-9 market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 173 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Carbohydrate Antigen 19-9 competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Carbohydrate antigen 19-9 is a tetrasaccharide which is usually attached to O-glycans on the surface of cells. It is known to play a vital role in cell-to-cell recognition processes. It is also a tumor marker used primarily in the management of pancreatic cancer.
Global Carbohydrate Antigen 19-9 main manufactuers include Abbott, Ropv and Ortho Clinical Diagnostics. In terms of the type of Carbohydrate Antigen 19-9, it can be divided into ELISA and CLIA. CLIA is the largest market, with a share over 70%.
This report delivers a comprehensive overview of the global Carbohydrate Antigen 19-9 market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Carbohydrate Antigen 19-9. The Carbohydrate Antigen 19-9 market size, estimates, and forecasts are provided in terms of sales volume (K Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Carbohydrate Antigen 19-9 market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Carbohydrate Antigen 19-9 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott
Roche
Ortho Clinical Diagnostics
BioMérieux
Fujirebio
KAINOS Laboratories
DiaSorin
Danaher Corporation
Siemens
Tellgen
DIACHA Diagnostics
Sichuan Maccura Biotechnology
Dirui
Chemclin IVD
Segment by Type
ELISA
CLIA
by Application
Pancreatic Cancer
Colon Cancer
Stomach Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Carbohydrate Antigen 19-9 manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Carbohydrate Antigen 19-9 sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Carbohydrate Antigen 19-9 Market Overview
1.1 Product Definition
1.2 Carbohydrate Antigen 19-9 by Type
1.2.1 Global Carbohydrate Antigen 19-9 Market Value by Type: 2025 vs 2032
1.2.2 ELISA
1.2.3 CLIA
1.3 Carbohydrate Antigen 19-9 by Application
1.3.1 Global Carbohydrate Antigen 19-9 Market Value by Application: 2025 vs 2032
1.3.2 Pancreatic Cancer
1.3.3 Colon Cancer
1.3.4 Stomach Cancer
1.3.5 Others
1.4 Global Carbohydrate Antigen 19-9 Market Size Estimates and Forecasts
1.4.1 Global Carbohydrate Antigen 19-9 Revenue 2021–2032
1.4.2 Global Carbohydrate Antigen 19-9 Sales 2021–2032
1.4.3 Global Carbohydrate Antigen 19-9 Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Carbohydrate Antigen 19-9 Market Competition by Manufacturers
2.1 Global Carbohydrate Antigen 19-9 Sales Market Share by Manufacturers (2021–2026)
2.2 Global Carbohydrate Antigen 19-9 Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Carbohydrate Antigen 19-9 Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Carbohydrate Antigen 19-9, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Carbohydrate Antigen 19-9, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Carbohydrate Antigen 19-9, Product Types and Applications
2.7 Global Key Manufacturers of Carbohydrate Antigen 19-9, Date of Entry into the Industry
2.8 Global Carbohydrate Antigen 19-9 Market Competitive Situation and Trends
2.8.1 Global Carbohydrate Antigen 19-9 Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Carbohydrate Antigen 19-9 Players Market Share by Revenue
2.8.3 Global Carbohydrate Antigen 19-9 Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Carbohydrate Antigen 19-9 Market Scenario by Region
3.1 Global Carbohydrate Antigen 19-9 Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Carbohydrate Antigen 19-9 Sales by Region: 2021–2032
3.2.1 Global Carbohydrate Antigen 19-9 Sales by Region: 2021–2026
3.2.2 Global Carbohydrate Antigen 19-9 Sales by Region: 2027–2032
3.3 Global Carbohydrate Antigen 19-9 Revenue by Region: 2021–2032
3.3.1 Global Carbohydrate Antigen 19-9 Revenue by Region: 2021–2026
3.3.2 Global Carbohydrate Antigen 19-9 Revenue by Region: 2027–2032
3.4 North America Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.4.1 North America Carbohydrate Antigen 19-9 Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Carbohydrate Antigen 19-9 Sales by Country (2021–2032)
3.4.3 North America Carbohydrate Antigen 19-9 Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.5.1 Europe Carbohydrate Antigen 19-9 Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Carbohydrate Antigen 19-9 Sales by Country (2021–2032)
3.5.3 Europe Carbohydrate Antigen 19-9 Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Carbohydrate Antigen 19-9 Market Facts & Figures by Region
3.6.1 Asia Pacific Carbohydrate Antigen 19-9 Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Carbohydrate Antigen 19-9 Sales by Region (2021–2032)
3.6.3 Asia Pacific Carbohydrate Antigen 19-9 Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.7.1 Latin America Carbohydrate Antigen 19-9 Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Carbohydrate Antigen 19-9 Sales by Country (2021–2032)
3.7.3 Latin America Carbohydrate Antigen 19-9 Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.8.1 Middle East and Africa Carbohydrate Antigen 19-9 Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2021–2032)
3.8.3 Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Carbohydrate Antigen 19-9 Sales by Type (2021–2032)
4.1.1 Global Carbohydrate Antigen 19-9 Sales by Type (2021–2026)
4.1.2 Global Carbohydrate Antigen 19-9 Sales by Type (2027–2032)
4.1.3 Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2021–2032)
4.2 Global Carbohydrate Antigen 19-9 Revenue by Type (2021–2032)
4.2.1 Global Carbohydrate Antigen 19-9 Revenue by Type (2021–2026)
4.2.2 Global Carbohydrate Antigen 19-9 Revenue by Type (2027–2032)
4.2.3 Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2021–2032)
4.3 Global Carbohydrate Antigen 19-9 Price by Type (2021–2032)
5 Segment by Application
5.1 Global Carbohydrate Antigen 19-9 Sales by Application (2021–2032)
5.1.1 Global Carbohydrate Antigen 19-9 Sales by Application (2021–2026)
5.1.2 Global Carbohydrate Antigen 19-9 Sales by Application (2027–2032)
5.1.3 Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2021–2032)
5.2 Global Carbohydrate Antigen 19-9 Revenue by Application (2021–2032)
5.2.1 Global Carbohydrate Antigen 19-9 Revenue by Application (2021–2026)
5.2.2 Global Carbohydrate Antigen 19-9 Revenue by Application (2027–2032)
5.2.3 Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2021–2032)
5.3 Global Carbohydrate Antigen 19-9 Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Carbohydrate Antigen 19-9 Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Roche Carbohydrate Antigen 19-9 Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Ortho Clinical Diagnostics
6.3.1 Ortho Clinical Diagnostics Company Information
6.3.2 Ortho Clinical Diagnostics Description and Business Overview
6.3.3 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Portfolio
6.3.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.4 BioMérieux
6.4.1 BioMérieux Company Information
6.4.2 BioMérieux Description and Business Overview
6.4.3 BioMérieux Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BioMérieux Carbohydrate Antigen 19-9 Product Portfolio
6.4.5 BioMérieux Recent Developments/Updates
6.5 Fujirebio
6.5.1 Fujirebio Company Information
6.5.2 Fujirebio Description and Business Overview
6.5.3 Fujirebio Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fujirebio Carbohydrate Antigen 19-9 Product Portfolio
6.5.5 Fujirebio Recent Developments/Updates
6.6 KAINOS Laboratories
6.6.1 KAINOS Laboratories Company Information
6.6.2 KAINOS Laboratories Description and Business Overview
6.6.3 KAINOS Laboratories Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 KAINOS Laboratories Carbohydrate Antigen 19-9 Product Portfolio
6.6.5 KAINOS Laboratories Recent Developments/Updates
6.7 DiaSorin
6.7.1 DiaSorin Company Information
6.7.2 DiaSorin Description and Business Overview
6.7.3 DiaSorin Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 DiaSorin Carbohydrate Antigen 19-9 Product Portfolio
6.7.5 DiaSorin Recent Developments/Updates
6.8 Danaher Corporation
6.8.1 Danaher Corporation Company Information
6.8.2 Danaher Corporation Description and Business Overview
6.8.3 Danaher Corporation Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Danaher Corporation Carbohydrate Antigen 19-9 Product Portfolio
6.8.5 Danaher Corporation Recent Developments/Updates
6.9 Siemens
6.9.1 Siemens Company Information
6.9.2 Siemens Description and Business Overview
6.9.3 Siemens Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Siemens Carbohydrate Antigen 19-9 Product Portfolio
6.9.5 Siemens Recent Developments/Updates
6.10 Tellgen
6.10.1 Tellgen Company Information
6.10.2 Tellgen Description and Business Overview
6.10.3 Tellgen Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Tellgen Carbohydrate Antigen 19-9 Product Portfolio
6.10.5 Tellgen Recent Developments/Updates
6.11 DIACHA Diagnostics
6.11.1 DIACHA Diagnostics Company Information
6.11.2 DIACHA Diagnostics Description and Business Overview
6.11.3 DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Portfolio
6.11.5 DIACHA Diagnostics Recent Developments/Updates
6.12 Sichuan Maccura Biotechnology
6.12.1 Sichuan Maccura Biotechnology Company Information
6.12.2 Sichuan Maccura Biotechnology Description and Business Overview
6.12.3 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Portfolio
6.12.5 Sichuan Maccura Biotechnology Recent Developments/Updates
6.13 Dirui
6.13.1 Dirui Company Information
6.13.2 Dirui Description and Business Overview
6.13.3 Dirui Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Dirui Carbohydrate Antigen 19-9 Product Portfolio
6.13.5 Dirui Recent Developments/Updates
6.14 Chemclin IVD
6.14.1 Chemclin IVD Company Information
6.14.2 Chemclin IVD Description and Business Overview
6.14.3 Chemclin IVD Carbohydrate Antigen 19-9 Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Chemclin IVD Carbohydrate Antigen 19-9 Product Portfolio
6.14.5 Chemclin IVD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carbohydrate Antigen 19-9 Industry Chain Analysis
7.2 Carbohydrate Antigen 19-9 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carbohydrate Antigen 19-9 Production Mode & Process Analysis
7.4 Carbohydrate Antigen 19-9 Sales and Marketing
7.4.1 Carbohydrate Antigen 19-9 Sales Channels
7.4.2 Carbohydrate Antigen 19-9 Distributors
7.5 Carbohydrate Antigen 19-9 Customer Analysis
8 Carbohydrate Antigen 19-9 Market Dynamics
8.1 Carbohydrate Antigen 19-9 Industry Trends
8.2 Carbohydrate Antigen 19-9 Market Drivers
8.3 Carbohydrate Antigen 19-9 Market Challenges
8.4 Carbohydrate Antigen 19-9 Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Carbohydrate Antigen 19-9 Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Carbohydrate Antigen 19-9 Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Carbohydrate Antigen 19-9 Market Competitive Situation by Manufacturers in 2025
Table 4. Global Carbohydrate Antigen 19-9 Sales (K Doses) of Key Manufacturers (2021–2026)
Table 5. Global Carbohydrate Antigen 19-9 Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Carbohydrate Antigen 19-9 Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Carbohydrate Antigen 19-9 Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Carbohydrate Antigen 19-9 Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Carbohydrate Antigen 19-9, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Carbohydrate Antigen 19-9, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Carbohydrate Antigen 19-9, Product Types and Applications
Table 12. Global Key Manufacturers of Carbohydrate Antigen 19-9, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Carbohydrate Antigen 19-9 Companies by Tier (Tier 1, Tier 2, Tier 3), based on Carbohydrate Antigen 19-9 Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Carbohydrate Antigen 19-9 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Carbohydrate Antigen 19-9 Sales by Region (K Doses), 2021–2026
Table 18. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2021–2026)
Table 19. Global Carbohydrate Antigen 19-9 Sales by Region (K Doses), 2027–2032
Table 20. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2027–2032)
Table 21. Global Carbohydrate Antigen 19-9 Revenue by Region (US$ Million), 2021–2026
Table 22. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2021–2026)
Table 23. Global Carbohydrate Antigen 19-9 Revenue by Region (US$ Million), 2027–2032
Table 24. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2027–2032)
Table 25. North America Carbohydrate Antigen 19-9 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Carbohydrate Antigen 19-9 Sales by Country (K Doses), 2021–2026
Table 27. North America Carbohydrate Antigen 19-9 Sales by Country (K Doses), 2027–2032
Table 28. North America Carbohydrate Antigen 19-9 Revenue by Country (US$ Million), 2021–2026
Table 29. North America Carbohydrate Antigen 19-9 Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Carbohydrate Antigen 19-9 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Carbohydrate Antigen 19-9 Sales by Country (K Doses), 2021–2026
Table 32. Europe Carbohydrate Antigen 19-9 Sales by Country (K Doses), 2027–2032
Table 33. Europe Carbohydrate Antigen 19-9 Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Carbohydrate Antigen 19-9 Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Carbohydrate Antigen 19-9 Sales by Region (K Doses), 2021–2026
Table 37. Asia Pacific Carbohydrate Antigen 19-9 Sales by Region (K Doses), 2027–2032
Table 38. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Carbohydrate Antigen 19-9 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Carbohydrate Antigen 19-9 Sales by Country (K Doses), 2021–2026
Table 42. Latin America Carbohydrate Antigen 19-9 Sales by Country (K Doses), 2027–2032
Table 43. Latin America Carbohydrate Antigen 19-9 Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Carbohydrate Antigen 19-9 Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (K Doses), 2021–2026
Table 47. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (K Doses), 2027–2032
Table 48. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (US$ Million), 2027–2032
Table 50. Global Carbohydrate Antigen 19-9 Sales (K Doses) by Type (2021–2026)
Table 51. Global Carbohydrate Antigen 19-9 Sales (K Doses) by Type (2027–2032)
Table 52. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2021–2026)
Table 53. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2027–2032)
Table 54. Global Carbohydrate Antigen 19-9 Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Carbohydrate Antigen 19-9 Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2021–2026)
Table 57. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2027–2032)
Table 58. Global Carbohydrate Antigen 19-9 Price (US$/Dose) by Type (2021–2026)
Table 59. Global Carbohydrate Antigen 19-9 Price (US$/Dose) by Type (2027–2032)
Table 60. Global Carbohydrate Antigen 19-9 Sales (K Doses) by Application (2021–2026)
Table 61. Global Carbohydrate Antigen 19-9 Sales (K Doses) by Application (2027–2032)
Table 62. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2021–2026)
Table 63. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2027–2032)
Table 64. Global Carbohydrate Antigen 19-9 Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Carbohydrate Antigen 19-9 Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2021–2026)
Table 67. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2027–2032)
Table 68. Global Carbohydrate Antigen 19-9 Price (US$/Dose) by Application (2021–2026)
Table 69. Global Carbohydrate Antigen 19-9 Price (US$/Dose) by Application (2027–2032)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Abbott Carbohydrate Antigen 19-9 Product
Table 74. Abbott Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Roche Carbohydrate Antigen 19-9 Product
Table 79. Roche Recent Developments/Updates
Table 80. Ortho Clinical Diagnostics Company Information
Table 81. Ortho Clinical Diagnostics Description and Business Overview
Table 82. Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product
Table 84. Ortho Clinical Diagnostics Recent Developments/Updates
Table 85. BioMérieux Company Information
Table 86. BioMérieux Description and Business Overview
Table 87. BioMérieux Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. BioMérieux Carbohydrate Antigen 19-9 Product
Table 89. BioMérieux Recent Developments/Updates
Table 90. Fujirebio Company Information
Table 91. Fujirebio Description and Business Overview
Table 92. Fujirebio Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Fujirebio Carbohydrate Antigen 19-9 Product
Table 94. Fujirebio Recent Developments/Updates
Table 95. KAINOS Laboratories Company Information
Table 96. KAINOS Laboratories Description and Business Overview
Table 97. KAINOS Laboratories Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. KAINOS Laboratories Carbohydrate Antigen 19-9 Product
Table 99. KAINOS Laboratories Recent Developments/Updates
Table 100. DiaSorin Company Information
Table 101. DiaSorin Description and Business Overview
Table 102. DiaSorin Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. DiaSorin Carbohydrate Antigen 19-9 Product
Table 104. DiaSorin Recent Developments/Updates
Table 105. Danaher Corporation Company Information
Table 106. Danaher Corporation Description and Business Overview
Table 107. Danaher Corporation Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Danaher Corporation Carbohydrate Antigen 19-9 Product
Table 109. Danaher Corporation Recent Developments/Updates
Table 110. Siemens Company Information
Table 111. Siemens Description and Business Overview
Table 112. Siemens Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Siemens Carbohydrate Antigen 19-9 Product
Table 114. Siemens Recent Developments/Updates
Table 115. Tellgen Company Information
Table 116. Tellgen Description and Business Overview
Table 117. Tellgen Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Tellgen Carbohydrate Antigen 19-9 Product
Table 119. Tellgen Recent Developments/Updates
Table 120. DIACHA Diagnostics Company Information
Table 121. DIACHA Diagnostics Description and Business Overview
Table 122. DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. DIACHA Diagnostics Carbohydrate Antigen 19-9 Product
Table 124. DIACHA Diagnostics Recent Developments/Updates
Table 125. Sichuan Maccura Biotechnology Company Information
Table 126. Sichuan Maccura Biotechnology Description and Business Overview
Table 127. Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product
Table 129. Sichuan Maccura Biotechnology Recent Developments/Updates
Table 130. Dirui Company Information
Table 131. Dirui Description and Business Overview
Table 132. Dirui Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 133. Dirui Carbohydrate Antigen 19-9 Product
Table 134. Dirui Recent Developments/Updates
Table 135. Chemclin IVD Company Information
Table 136. Chemclin IVD Description and Business Overview
Table 137. Chemclin IVD Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 138. Chemclin IVD Carbohydrate Antigen 19-9 Product
Table 139. Chemclin IVD Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Carbohydrate Antigen 19-9 Distributors List
Table 143. Carbohydrate Antigen 19-9 Customers List
Table 144. Carbohydrate Antigen 19-9 Market Trends
Table 145. Carbohydrate Antigen 19-9 Market Drivers
Table 146. Carbohydrate Antigen 19-9 Market Challenges
Table 147. Carbohydrate Antigen 19-9 Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Carbohydrate Antigen 19-9
Figure 2. Global Carbohydrate Antigen 19-9 Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Carbohydrate Antigen 19-9 Market Share by Type: 2025 & 2032
Figure 4. ELISA Product Picture
Figure 5. CLIA Product Picture
Figure 6. Global Carbohydrate Antigen 19-9 Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Carbohydrate Antigen 19-9 Market Share by Application: 2025 & 2032
Figure 8. Pancreatic Cancer
Figure 9. Colon Cancer
Figure 10. Stomach Cancer
Figure 11. Others
Figure 12. Global Carbohydrate Antigen 19-9 Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Carbohydrate Antigen 19-9 Market Size (US$ Million), 2021–2032
Figure 14. Global Carbohydrate Antigen 19-9 Sales (K Doses), 2021–2032
Figure 15. Global Carbohydrate Antigen 19-9 Average Price (US$/Dose), 2021–2032
Figure 16. Carbohydrate Antigen 19-9 Report Years Considered
Figure 17. Carbohydrate Antigen 19-9 Sales Share by Manufacturers in 2025
Figure 18. Global Carbohydrate Antigen 19-9 Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Carbohydrate Antigen 19-9 Players: Market Share by Revenue in Carbohydrate Antigen 19-9 in 2025
Figure 20. Carbohydrate Antigen 19-9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Carbohydrate Antigen 19-9 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Carbohydrate Antigen 19-9 Sales Market Share by Country (2021–2032)
Figure 23. North America Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021–2032)
Figure 24. United States Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Carbohydrate Antigen 19-9 Sales Market Share by Country (2021–2032)
Figure 27. Europe Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021–2032)
Figure 28. Germany Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Carbohydrate Antigen 19-9 Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Carbohydrate Antigen 19-9 Revenue Market Share by Region (2021–2032)
Figure 35. China Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Carbohydrate Antigen 19-9 Sales Market Share by Country (2021–2032)
Figure 45. Latin America Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Carbohydrate Antigen 19-9 Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Carbohydrate Antigen 19-9 Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Carbohydrate Antigen 19-9 by Type (2021–2032)
Figure 55. Global Revenue Market Share of Carbohydrate Antigen 19-9 by Type (2021–2032)
Figure 56. Global Carbohydrate Antigen 19-9 Price (US$/Dose) by Type (2021–2032)
Figure 57. Global Sales Market Share of Carbohydrate Antigen 19-9 by Application (2021–2032)
Figure 58. Global Revenue Market Share of Carbohydrate Antigen 19-9 by Application (2021–2032)
Figure 59. Global Carbohydrate Antigen 19-9 Price (US$/Dose) by Application (2021–2032)
Figure 60. Carbohydrate Antigen 19-9 Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
